[{"Assets_0_Q2_USD":"1126724000.0","CIK":"1737287","CommonStockSharesConverted_0_Q2_shares":"142120731.0","CommonStockSharesOutstanding_0_Q2_shares":"142120731.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.53","EarningsPerShareBasic_2_Q2_USD":"-0.78","EarningsPerShareDiluted_1_Q2_USD":"-0.53","EarningsPerShareDiluted_2_Q2_USD":"-0.78","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-90498000.0","NetIncomeLoss_1_Q2_USD":"-70936000.0","NetIncomeLoss_2_Q2_USD":"-103951000.0","OfficialName":"Allogene Therapeutics Inc. Common Stock","ProfitLoss_2_Q2_USD":"-103951000.0","RevenuesConverted_1_Q2_USD":"44000.0","RevenuesConverted_2_Q2_USD":"38389000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"1023812000.0","Ticker":"ALLO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"134826805.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"133503262.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"134826805.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"133503262.0","filed":"20210804","footnote":null,"form":"10-Q","fp":"Q2","fy":"2021.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20210630","qtrs":"0","uom":"USD"}]